Clinical Trials on Borderline Resectable Adenocarcinoma of the Head of the Pancrease
Total 9779 results
-
Thomas Jefferson UniversityAlexion Pharmaceuticals, Inc.Completed
-
Pamukkale UniversityCompletedMultiple Sclerosis | Proprioceptive Disorders | Reliability | Validity | Sensory ImpairmentsTurkey
-
Fujian Medical UniversityCompletedPatients With More Than or Equal to One of the Following Criteria Were Defined as High-risk Patients
-
Mayo ClinicAlexion Pharmaceuticals, Inc.Completed
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisBelgium, Germany, Italy, Norway, France, Mexico, Australia, Spain, Portugal, Greece, Netherlands, United Kingdom, Czechia, Slovakia, Finland, Canada, Argentina, Brazil
-
IRCCS Fondazione Stella MarisAzienda Ospedaliero, Universitaria PisanaCompletedEpilepsy | Multiple Sclerosis | Neurodegenerative Diseases | Neurodevelopmental Disorders | Brain TumorItaly
-
Virginia Commonwealth UniversityIcahn School of Medicine at Mount Sinai; The Cleveland Clinic; Weill Medical... and other collaboratorsCompletedCardiomyopathy | Sarcoidosis of the HeartUnited States
-
Ohio State UniversityNational Multiple Sclerosis SocietyCompleted
-
Zimmer BiometCompletedOsteoarthritis | Traumatic Arthritis | Avascular Necrosis of the Femoral Condyle | Moderate Varus | Valgus | Flexion DeformitiesUnited States
-
Hoffmann-La RocheChugai Pharmaceutical Co., Ltd. (Sponsor in Taiwan and Japan)Withdrawn
-
University of Iowajkamholz; cdworkmanCompletedMultiple SclerosisUnited States
-
Harbour BioMed (Guangzhou) Co. Ltd.Completed
-
BiocadCompletedRelapsing-remitting Multiple Sclerosis
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedRelapsing-remitting Multiple SclerosisUnited States, Germany
-
Charite University, Berlin, GermanyDr. Carmen Infante-DuarteTerminatedRelapsing-Remitting Multiple SclerosisGermany
-
Ege UniversityCompletedMultiple Sclerosis | Neuro-Degenerative Disease | Exercise InterventionTurkey
-
EMD Serono Research & Development Institute, Inc.CompletedRelapsing-Remitting Multiple SclerosisCroatia, United States, Bulgaria, France, Italy, Russian Federation, Turkey, United Kingdom, Estonia, Germany, Latvia, Lithuania, Poland, Austria, Brazil, Canada, Finland, Portugal, Greece, Serbia, Denmark, Ukraine, Saudi Arabia, Lebanon and more
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple SclerosisFrance, Italy, Spain, Czechia, Hungary, Austria, Belgium, Canada, Portugal, Slovakia, Slovenia
-
Lebanese American UniversityUnknown
-
Northwestern UniversityCompleted
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedRelapsing-Remitting Multiple SclerosisUnited States
-
National Cancer Institute (NCI)TerminatedCentral Nervous System Neoplasms | Brain Cancer | Neoplasms, Brain | Primary Brain Neoplasms | Cancer of the BrainUnited States
-
Texas Woman's UniversityThe University of Texas Health Science Center, Houston; TIRR Memorial HermannUnknownMultiple Sclerosis | Cognitive Impairment | Gait Disorders, NeurologicUnited States
-
Amanda IrishCompletedMultiple Sclerosis, Relapsing-remittingUnited States
-
Novartis PharmaceuticalsCompletedRelapsing-remitting Multiple SclerosisGermany
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple SclerosisKorea, Republic of, Taiwan, Czechia, Japan, Poland
-
Eli Lilly and CompanyCompletedRelapsing-Remitting Multiple SclerosisHungary, United States, France, Ukraine, Poland, Germany, Israel, Russian Federation, Czechia, Serbia, Romania, Slovakia, Bulgaria
-
BiogenAbbVieCompletedRelapsing-Remitting Multiple SclerosisGermany, Hungary, Czechia, Russian Federation, India, Poland, Ukraine, United Kingdom
-
University of IowaDJO Incorporated; Direct MS Canada; Pinnaclife Inc.; TZ Press, LLCCompletedMultiple SclerosisUnited States
-
Nantes University HospitalCompletedRelapsing-remitting Multiple SclerosisFrance
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisGermany
-
GenticelPPDTerminatedHPV 16- and/or HPV 18-Infected Women With Normal Cytology, ASCUS, or LSILUnited States
-
Universita di VeronaCompletedRelapsing-Remitting Multiple SclerosisItaly
-
BiogenAbbVieCompletedRelapsing-Remitting Multiple SclerosisCzech Republic, Poland, Russian Federation, United Kingdom, Hungary, Ukraine, Germany, India
-
BiogenAbbVieCompletedRelapsing-Remitting Multiple SclerosisSweden, United States, Brazil, Czech Republic, Italy, Russian Federation, Spain, United Kingdom, Germany, Ukraine, Denmark, Finland, Romania, Canada, France, Hungary, Israel, Switzerland, Serbia, India, Mexico, Poland, Georgia, Ireland, Argentin... and more
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisItaly
-
AllerganCompletedMultiple Sclerosis | Urinary Bladder DiseasesUnited States
-
Mitsubishi Tanabe Pharma CorporationCompletedRelapsing-remitting Multiple SclerosisBelgium, Bulgaria, Canada, Croatia, Czech Republic, Finland, Germany, Hungary, Italy, Lithuania, Poland, Russian Federation, Serbia, Spain, Turkey, Ukraine, United Kingdom
-
Queen Margaret UniversityNHS Lothian; Multiple Sclerosis Society UKCompletedMultiple Sclerosis | Foot DropUnited Kingdom
-
National Institute of Neurological Disorders and...Terminated
-
S. Anna HospitalRegione Emilia-RomagnaCompletedMultiple Sclerosis | Venous InsufficiencyItaly
-
Emory UniversityTerminated
-
Claudio GobbiOspedale Civico, LuganoCompletedRelapsing-remitting Multiple SclerosisSwitzerland
-
Merck KGaA, Darmstadt, GermanyCompleted
-
Claudio GobbiBayerTerminatedRelapsing-remitting Multiple SclerosisSwitzerland
-
Merck KGaA, Darmstadt, GermanyMerck Serono S.A.S, FranceCompletedMultiple Sclerosis, Relapsing, Remitting
-
Coordinación de Investigación en Salud, MexicoCompleted
-
University of ManitobaBausch Health Americas, Inc.CompletedMultiple Sclerosis | Neuropathic PainCanada
-
NovartisCompletedEfficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis (FREEDOMS)Relapsing-remitting Multiple SclerosisCanada, Australia, Israel, Belgium, Czech Republic, Finland, France, Germany, Greece, Lithuania, Netherlands, Poland, Russian Federation, Slovakia, South Africa, Sweden, Switzerland, Turkey, United Kingdom
-
Universita di VeronaCompletedRelapsing-remitting Multiple SclerosisItaly